A meta-analysis and systematic review of 5-aminosalicylates withdrawal in Inflammatory Bowel Disease

被引:0
|
作者
Arzivian, A. [1 ]
Kerkham, A. [2 ]
Tran, Y. [3 ]
Rubin, D. [4 ]
Leong, R. [1 ]
机构
[1] Macquarie Univ Hosp, Gastroenterol & Hepatol Dept, Sydney, Australia
[2] Nepean Hosp, Gastroenterol & Hepatol Dept, Sydney, Australia
[3] Macquarie Univ, Dept Hlth Sci, Sydney, Australia
[4] Univ Chicago, Ctr Inflammatory Bowel Dis, Chicago, IL USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P1000
引用
收藏
页码:I1804 / I1804
页数:1
相关论文
共 50 条
  • [21] Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein, CN
    Blanchard, JF
    Metge, C
    Yogendran, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (12): : 2784 - 2788
  • [22] Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein, CN
    Metge, C
    Blanchard, JF
    Yogendran, M
    GASTROENTEROLOGY, 2003, 124 (04) : A36 - A36
  • [23] Polypharmacy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Mohamed, Mouhand F. H.
    Kwon, Michelle
    Beran, Azizullah
    Elfert, Khaled
    Shah, Samir A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S911 - S912
  • [24] Systematic review with meta-analysis: inflammatory bowel disease in the elderly
    Gisbert, J. P.
    Chaparro, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (05) : 459 - 477
  • [25] The prevalence of migraine in patients with inflammatory bowel disease (IBD), a systematic review and meta-analysis The prevalence of migraine in Inflammatory bowel disease, a systematic review and meta-analysis
    Olfati, Hamide
    Mirmosayyeb, Omid
    Hosseinabadi, Ali
    Ghajarzadeh, Mahsa
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01)
  • [26] Efficacy of Oral,Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis
    Barberio, Brigida
    Segal, Jonathan P.
    Quraishi, M. Nabil
    Black, Christopher J.
    Savarino, Edoardo, V
    Ford, Alexander C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (07): : 1184 - 1196
  • [27] WITHDRAWAL OF IMMUNOMODULATORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN REMISSION ON COMBINATION THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Katibian, David J.
    Solitano, Virginia
    Polk, D. Brent
    Nguyen, Tran M.
    Ma, Christopher
    Jairath, Vipul
    Singh, Siddharth
    GASTROENTEROLOGY, 2023, 164 (06) : S652 - S653
  • [28] Clinical outcomes for ulcerative colitis patients stopping 5-aminosalicylates starting biologics and/or immunomodulator therapy: A Systematic review and meta-analysis
    Moon, J. R.
    Na, J. E.
    Ji, J. H.
    Lee, H. S.
    Park, J. J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1890 - I1890
  • [29] Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Gu, Phillip
    Kuenzig, M. Ellen
    Kaplan, Gilaad G.
    Pimentel, Mark
    Rezaie, Ali
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) : 1280 - 1290
  • [30] Usefulness of Procalcitonin in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
    Cheung, Donna Ann
    Tamariz, Leonardo
    Nemeth, Zsuzsanna
    Langshaw, Amber Hamid
    CROHNS & COLITIS 360, 2019, 1 (03)